Scrip
Eisai gives up on sibutramine in Japan
October 28, 2010
Ian Haydock
Eisai has withdrawn a Japanese approval application for the obesity drug sibutramine, following originator Abbott's decision to pull the product from several major markets.
Eisai held exclusive development and marketing rights in Japan and had filed for sibutramine's approval in November 2007,
October 28, 2010
Ian Haydock
Eisai has withdrawn a Japanese approval application for the obesity drug sibutramine, following originator Abbott's decision to pull the product from several major markets.
Eisai held exclusive development and marketing rights in Japan and had filed for sibutramine's approval in November 2007,
No hay comentarios:
Publicar un comentario